Use of Ultralong-Acting Basal Insulin in a 59-Year-Old Woman with Type 2 Diabetes and Hypoglycemia on Conventional Basal Insulin Therapy

Use of Ultralong-Acting Basal Insulin in a 59-Year-Old Woman with Type 2 Diabetes and Hypoglycemia on Conventional Basal Insulin Therapy is organized by Pri-Med and will be held from Jul 20, 2018 - Jul 20, 2019.

Credits:
0.75 AMA PRA Category 1 Credits™ or 0.69 AANP, including 0.52 AANP Pharm

Overview :
In this case presentation, Dr. Mathioudakis shares strategies for treatment intensification while minimizing the risk of hypoglycemia and highlights the differences between conventional and newer basal insulin products. He also describes how to appropriately initiate and dose newer basal insulin products in patients with type 2 diabetes.

Learning Objectives :
• Recognize the differences between conventional and newer basal insulins
• Apply strategies for selection, initiation, titration, and intensification of basal insulin while minimizing the risk of hypoglycemia
• Describe the impact of hypoglycemia on clinical and patient-reported outcomes

Additional details will be posted as soon as they are available.